⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR
globenewswire.com
ABBV
AMGN
PFE
BMY
MRK
REGN
SNY
TAK
NVS
GSK
HRTX
Discovery Could Make Immune Checkpoint Inhibitors Safer
prnewswire.com
BMY
MRK
Veterinary Vaccines Market Forecast 2026-2036: Industry to Reach USD 18.2 Billion by 2036 at 5.4% CAGR
accessnewswire.com
ZTS
ELAN
MRK
PAHC
50/50 Women on Boards™ to Open 2026 Global Summit with The Breakfast of Corporate Champions
prnewswire.com
ACN
MRK
GM
Global Respiratory Syncytial Virus (RSV) Vaccines Market to Reach $1.24 Billion by 2030 | MarketsandMarkets™
globenewswire.com
PFE
MRNA
MRK
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players
globenewswire.com
MRK
BRKR
TMO
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More
globenewswire.com
TMO
DHR
MRK
Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons
businesswire.com
MRK
Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ Drugs - Collaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech
globenewswire.com
MRK
PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 200+ Drugs from Over 180 Companies by Company, Product Type, Stage, Route of Administration, and Molecule Type
globenewswire.com
MRK
AZN